|
66 Companies |
|
64 Products |
|
64 Products |
|
38 Mechanisms of Action |
|
0 Trials |
|
1520 News |
|
| «12...678910111213141516...3031» |
- |||| Fluzone Quadrivalent (influenza vaccine) / Sanofi
Trial completion: Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine (clinicaltrials.gov) - Sep 28, 2014
P4, N=60, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
Active, not recruiting --> Completed
- ||||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, Fluzone (influenza vaccine) / Sanofi, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
New P4 trial: Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents (clinicaltrials.gov) - Sep 28, 2014
P4, N=180, Enrolling by invitation, Sponsor: Marshfield Clinic Research Foundation
- ||||| New P1/2 trial, Preclinical: Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine) (clinicaltrials.gov) - Sep 28, 2014
P1/2, N=84, Not yet recruiting, Sponsor: Green Cross Corporation
- |||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, Fluzone (influenza vaccine) / Sanofi, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Enrollment open: Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents (clinicaltrials.gov) - Sep 28, 2014
P4, N=180, Enrolling by invitation, Sponsor: Marshfield Clinic Research Foundation
Active, not recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- ||| Fluzone Quadrivalent (influenza vaccine) / Sanofi
Enrollment closed: Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (clinicaltrials.gov) - Sep 28, 2014
P4, N=60, Active, not recruiting, Sponsor: Sanofi Pasteur, a Sanofi Company
Not yet recruiting --> Enrolling by invitation Recruiting --> Active, not recruiting
- Trial completion, Enrollment change: Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11 (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=2351, Completed, Sponsor: National Institute for Health and Welfare, Finland
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=3000 --> 2351
- Trial completion: Evaluation of Pandemic Vaccination Campaign (clinicaltrials.gov) - Sep 28, 2014
P4, N=3518, Completed, Sponsor: National Institute for Health and Welfare, Finland
Active, not recruiting --> Completed | N=3000 --> 2351 Active, not recruiting --> Completed
- |||| Fluzone Quadrivalent (influenza vaccine) / Sanofi
Enrollment open: A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years (clinicaltrials.gov) - Sep 28, 2014
P4, N=400, Recruiting, Sponsor: bioCSL PTY LTD
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||| PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Enrollment open: Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults. (clinicaltrials.gov) - Sep 28, 2014
P4, N=882, Recruiting, Sponsor: Pfizer
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- VIS410 / Otsuka
Enrollment open, Enrollment change: A Study of VIS410 to Assess Safety and Pharmacokinetics (clinicaltrials.gov) - Sep 28, 2014
P1, N=41, Recruiting, Sponsor: Visterra, Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | N=30 --> 41
- | chlorpheniramine / Generic mfg., paracetamol / Generic mfg., dextromethorphan / Generic mfg.
New P4 trial: The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza. (clinicaltrials.gov) - Sep 22, 2014
P4, N=50, Not yet recruiting, Sponsor: GlaxoSmithKline
- ||||| Enrollment closed: A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above. (clinicaltrials.gov) - Sep 22, 2014
P3, N=3480, Active, not recruiting, Sponsor: bioCSL PTY LTD
Not yet recruiting --> Recruiting | N=30 --> 41 Recruiting --> Active, not recruiting
- ||| Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
Enrollment closed, Trial primary completion date: Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy (clinicaltrials.gov) - Sep 22, 2014
P2, N=120, Active, not recruiting, Sponsor: Saad Jamshed MD
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Sep 2014
- ||||| Enrollment change: Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America (clinicaltrials.gov) - Sep 19, 2014
P3, N=1200, Not yet recruiting, Sponsor: Pfizer
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Sep 2014 N=795 --> 1200
- |||||||||| FluLaval Quadrivalent (influenza vaccine) / GSK
New P3 trial: Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age (clinicaltrials.gov) - Sep 19, 2014
P3, N=2950, Not yet recruiting, Sponsor: GlaxoSmithKline
- | Phase classification: A Study to Describe Pediatric Influenza Vaccine Coverage (clinicaltrials.gov) - Sep 15, 2014
P4, N=147494, Completed, Sponsor: MedImmune LLC
N=795 --> 1200 Phase classification: P=N/A --> P4
- paracetamol / Generic mfg., ibuprofen / Generic mfg.
Enrollment open: The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine (clinicaltrials.gov) - Sep 15, 2014
P4, N=160, Recruiting, Sponsor: Duke University
Phase classification: P=N/A --> P4 Not yet recruiting --> Recruiting
- Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
Trial completion, Enrollment change: Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV (clinicaltrials.gov) - Sep 12, 2014
P2, N=85, Completed, Sponsor: St. Jude Children's Research Hospital
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=280 --> 85
- Clinical: Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis? (clinicaltrials.gov) - Sep 10, 2014
P=N/A, N=20, Recruiting, Sponsor: University of Aarhus
- ||||| Plegridy (PEG-interferon ?-1a) / Biogen
New P4 trial: Frequency: Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy (clinicaltrials.gov) - Sep 9, 2014
P4, N=1200, Not yet recruiting, Sponsor: Biogen Idec
- ||| IVACFLU-A/H5N1 (whole virion monovalent A/H5N1 influenza vaccine) - Institute of Vaccines and Biological Medical / IVAC
Trial completion: Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1 (clinicaltrials.gov) - Sep 9, 2014
P1, N=75, Completed, Sponsor: Institute of Vaccines and Medical Biologicals (IVAC)
Active, not recruiting --> Completed | N=280 --> 85 Recruiting --> Completed
- Clinical: The Role of the Cervical Spine in Carpal Tunnel Syndrome (clinicaltrials.gov) - Sep 8, 2014
P=N/A, N=100, Recruiting, Sponsor: Universidad Rey Juan Carlos
- |||| Enrollment open: Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China (clinicaltrials.gov) - Sep 8, 2014
P4, N=600, Recruiting, Sponsor: Sanofi Pasteur, a Sanofi Company
Recruiting --> Completed Not yet recruiting --> Recruiting
- || Trial primary completion date: Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years (clinicaltrials.gov) - Sep 5, 2014
P2, N=469, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Trial primary completion date: Dec 2009 --> May 2009
- Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
Trial primary completion date: Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults (clinicaltrials.gov) - Sep 5, 2014
P2, N=360, Recruiting, Sponsor: University of Colorado, Denver
Trial primary completion date: Dec 2009 --> May 2009 Trial primary completion date: Sep 2014 --> Sep 2015
- ||| Enrollment open: Influenza Vaccination in Cancer Patients (clinicaltrials.gov) - Sep 5, 2014
P=N/A, N=130, Recruiting, Sponsor: Seoul National University Hospital
Trial primary completion date: Sep 2014 --> Sep 2015 Not yet recruiting --> Recruiting
- Enrollment open, Enrollment change: A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1 (clinicaltrials.gov) - Sep 5, 2014
P1, N=72, Recruiting, Sponsor: University of Oxford
Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting | N=48 --> 72
- || Enrollment closed, Trial primary completion date: Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. (clinicaltrials.gov) - Sep 5, 2014
P1, N=100, Active, not recruiting, Sponsor: Medicago
Active, not recruiting --> Recruiting | N=48 --> 72 Not yet recruiting --> Active, not recruiting | Trial primary completion date: Apr 2014 --> Sep 2014
- | New P2 trial: Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine (clinicaltrials.gov) - Sep 4, 2014
P2, N=60, Active, not recruiting, Sponsor: Mahidol University
- |||||| Fluarix Quadrivalent (influenza vaccine) / GSK
Enrollment open: A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children (clinicaltrials.gov) - Sep 4, 2014
P3, N=1860, Recruiting, Sponsor: GlaxoSmithKline
Not yet recruiting --> Active, not recruiting | Trial primary completion date: Apr 2014 --> Sep 2014 Not yet recruiting --> Recruiting
- Clinical: SKIPP RCT: Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New York (clinicaltrials.gov) - Aug 29, 2014
P=N/A, N=39000, Not yet recruiting, Sponsor: University of Rochester
- ||||| New P4 trial: Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China (clinicaltrials.gov) - Aug 29, 2014
P4, N=600, Not yet recruiting, Sponsor: Sanofi Pasteur, a Sanofi Company
- Trial primary completion date: Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults (clinicaltrials.gov) - Aug 27, 2014
P1, N=45, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Recruiting Trial primary completion date: Jun 2014 --> Jun 2015
- ||||||| Trial completion, Head-to-Head: Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old (clinicaltrials.gov) - Aug 26, 2014
P3, N=2349, Completed, Sponsor: Novartis Vaccines
Trial primary completion date: Jun 2014 --> Jun 2015 Active, not recruiting --> Completed
- ||||| FLUAD (trivalent inactivated influenza vaccine) / CSL Behring
New P4 trial: MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine (clinicaltrials.gov) - Aug 26, 2014
P4, N=224, Completed, Sponsor: Korea University Guro Hospital
- Enrollment change, Trial termination: Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy (clinicaltrials.gov) - Aug 25, 2014
P=N/A, N=6, Terminated, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed N=140 --> 6 | Active, not recruiting --> Terminated; Terminated due to lack of enrollment
- FluMist (influenza vaccine, live, intranasal) / AstraZeneca, Fluzone (influenza vaccine) / Sanofi, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial termination: Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants (clinicaltrials.gov) - Aug 22, 2014
P4, N=3, Terminated, Sponsor: University of Rochester
N=140 --> 6 | Active, not recruiting --> Terminated; Terminated due to lack of enrollment Completed --> Terminated; Insufficient enrollment
- |||| Fluzone Quadrivalent (influenza vaccine) / Sanofi
Enrollment open: Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (clinicaltrials.gov) - Aug 22, 2014
P4, N=60, Recruiting, Sponsor: Sanofi Pasteur, a Sanofi Company
Completed --> Terminated; Insufficient enrollment Not yet recruiting --> Recruiting
- ||| Clinical data, Trial completion, Enrollment change: Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients (clinicaltrials.gov) - Aug 22, 2014
P=N/A, N=150, Completed, Sponsor: Crucell Holland BV
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=500 --> 150
- ||||| Fluzone Quadrivalent (influenza vaccine) / Sanofi
New P4 trial: Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (clinicaltrials.gov) - Aug 21, 2014
P4, N=60, Not yet recruiting, Sponsor: Sanofi Pasteur, a Sanofi Company
- |||||| Enrollment open: A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above. (clinicaltrials.gov) - Aug 21, 2014
P3, N=3480, Recruiting, Sponsor: bioCSL PTY LTD
Active, not recruiting --> Completed | N=500 --> 150 Not yet recruiting --> Recruiting
- Trial primary completion date: UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients (clinicaltrials.gov) - Aug 21, 2014
P=N/A, N=600, Recruiting, Sponsor: University of Arkansas
Not yet recruiting --> Recruiting Trial primary completion date: Nov 2014 --> Dec 2015
- ||| Trial completion, Trial primary completion date: Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine (clinicaltrials.gov) - Aug 21, 2014
P1, N=84, Completed, Sponsor: Crucell Holland BV
Trial primary completion date: Nov 2014 --> Dec 2015 Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2013
- |||||||||| Fluarix Quadrivalent (influenza vaccine) / GSK
New P3 trial: Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older (clinicaltrials.gov) - Aug 19, 2014
P3, N=356, Not yet recruiting, Sponsor: GlaxoSmithKline
- Enrollment closed, Trial primary completion date: A Clinical Trial of Splinting for DeQuervain's Tenosynovitis (clinicaltrials.gov) - Aug 15, 2014
P=N/A, N=80, Active, not recruiting, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2013 Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Feb 2014 --> Dec 2014
- |||| Trial completion: A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine) (clinicaltrials.gov) - Aug 15, 2014
P1/2, N=84, Completed, Sponsor: Green Cross Corporation
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Feb 2014 --> Dec 2014 Active, not recruiting --> Completed
- ||||| PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer, FLUAD (trivalent inactivated influenza vaccine) / CSL Behring
New P4 trial: Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ?60 Years (clinicaltrials.gov) - Aug 15, 2014
P4, N=1311, Not yet recruiting, Sponsor: Korea University Guro Hospital
- Phase classification, Trial primary completion date: Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People (clinicaltrials.gov) - Aug 12, 2014
P1/2, N=200, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Phase classification: P1 --> P1/2 | Trial primary completion date: Sep 2015 --> Dec 2015
- |||||||||| New P3 trial: A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above. (clinicaltrials.gov) - Aug 12, 2014
P3, N=3480, Not yet recruiting, Sponsor: bioCSL PTY LTD
- Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Enrollment open: Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults (clinicaltrials.gov) - Aug 12, 2014
P4, N=360, Recruiting, Sponsor: University of Witwatersrand, South Africa
Phase classification: P1 --> P1/2 | Trial primary completion date: Sep 2015 --> Dec 2015 Not yet recruiting --> Recruiting